Navigation Links
NASDAQ Gives Dynatronics a Third Three-Month Extension for Minimum Bid Price Compliance

SALT LAKE CITY, March 31 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that NASDAQ has filed a third grace period extension with the SEC, giving the company until approximately September 27, 2009, to comply with NASDAQ's $1 per share minimum bid rule.

"We are pleased that NASDAQ has again extended the timeframe for compliance," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "This will allow us time to announce our year-end results, which are expected to show significant improvement over the prior year."

Dynatronics recently reported a profit for the quarter ended December 31, 2008, showing substantially improved results for that period. The company also announced it had retained Vici Capital to assist in seeking ways to improve revenues and minimize expenses. Partly as a result of that process, the company has taken steps to reduce annual expenses by approximately $1,000,000. Additional savings are expected to be achieved in subsequent months from this effort.

"In the quarter ending June 30, 2009, we plan to introduce a new, high-margin product to the physical medicine market," Cullimore added. "The combination of new products, reduced expenses and improved revenues is expected to lead to significantly improved operating results and generate sustainable earnings improvements for the company."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at

This press release contains forward-looking statements. Those statements include references to the company's expectations for future events. Such statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements in this press release include the statements concerning anticipated improvements for the quarter ending June 30, 2009, the anticipated impact of the introduction of a new product in the quarter ending June 30, 2009, the expectation that changes implemented with the assistance of Vici Capital will reduce operating expenses by approximately $1,000,000, the expectation that additional savings are expected to be achieved in the coming months, and the statement that these developments are expected to lead to significantly improved operating results and generate sustainable earnings improvements for the company. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2008.

SOURCE Dynatronics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VirtualScopics Receives Further Extension to Regain Compliance With Nasdaq
2. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
3. NASDAQ Panel Grants Extension to DATATRAK for Continued Listing on the NASDAQ Capital Market
4. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
5. Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
6. The LCA-Vision Full Value Committee Urges LCA-Vision (NASDAQ: LCAV) Stockholders to Reject the Status Quo
7. Pharmacyclics Receives Nasdaq Notification
8. Mylan Vice Chairman and CEO Robert J. Coury to Ring NASDAQ Stock Market Opening Bell
9. Cell Therapeutics to Resume Trading on MTA and NASDAQ
10. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
11. EngagementHealth(R) Launches Comprehensive Wellness Programs With Rurban Financial Corp. (Nasdaq - RBNF)
Post Your Comments:
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology: